SPEAKERS
DR ALBERT P. LI
Dr Albert P. Li is the President, CEO and co-founder of In vitro ADMET Laboratories LLC, Columbia, MD and Malden, MA, USA. He has devoted his scientific career to the development and advancement of scientific concepts and in vitro technologies to accurately predict human drug properties including metabolic fate, drug-drug interaction potential, and organ-specific toxicity. His research is focused on the development and application of human-based in vitro experimental models, especially primary cultured human hepatocytes and most recently, enterocytes, in the accurate assessment of human drug properties including metabolic fate, drug-drug interactions and drug toxicity. Dr. Li holds several U.S and international patents, including the Quick Refreezeâ„¢ process to produce highly-functional pooled cryopreserved human hepatocytes, the Integrated Discrete Multiple Organ Co-culture (IdMOCâ„¢) system, used to co-culture multiple cell types, thus modeling the multiple organs in the human body that are interconnected by the systemic circulation, and the plated hepatocyte relay assay for the evaluation of slowly metabolized compounds.
PROF. DR. M. A. AKBARSHA
Currenlty he is the Research Co-ordinator, National College (Autonomous), Tiruchirappalli. Formerly he was the Director and Chair of Mahatma Gandhi-Doerenkamp Center (MGDC), Bharathidasan University, Tiruchirappalli. He started his career as a demonstrator in Zoology at Jamal Mohamed College, Tiruchirappalli (1970-1975), and he took up positions as an Asst. Professor and Professor during 1975-1986. Other notable positions include Deputy Controller of Exams at Bharathidasan University during (1986-89); Reader in the School of Life Sciences, Bharathidasan University (1989-95); Professor of Department of Animal Science (1995-2008); Head, Department of Animal Science (1998-2008); Coordinator, School of Life Sciences (2002-2008) and Dean, Faculty of Science (2004-2006). Most of his research is concerned with in vitro Sciences, Reproductive Biology, and Drug Discovery for cancer and obesity. He is also Editor-in-Chief of Journal of Endocrinology and Reproduction and General Secretary of Society for Alternatives to Animal Experiments (SAAE-I).